Roswitha Runge - Concepedia

Author

Roswitha Runge

Also Known As

G. Wunderlich, Jana Arlt, L. Oehme, M. Wendisch, R Runge, R. Freudenberg, R. Hliscs, R. Runge, Roswitha Runge, Runge, R.

Publications

821

Citations

H-Index

Concepts

All Affiliations

University Hospital Carl Gustav Carus Technische Universität Dresden Helmholtz-Zentrum Dresden-Rossendorf OncoRay University Medical Centre Mannheim

About

Roswitha Runge is an author at University Hospital Carl Gustav Carus specializing in medicine, radiation oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	143
2	Health Sciences	2	2	101
3	Engineering	1	1	13
4	Natural Sciences	1	1	10
5	Biomolecular Engineering	1	1	10

Roswitha Runge

Publications

559

Citations

H-Index

Page 1

	Year	Citations
Dosimetry of 188Re-hydroxyethylidene diphosphonate in human prostate cancer skeletal metastases. Knut Liepe, R Hliscs, J. Kropp, PubMed	2003	86
The benefit of bone-seeking radiopharmaceuticals in the treatment of metastatic bone pain Knut Liepe, Roswitha Runge, J�rg Kotzerke Journal of Cancer Research and Clinical Oncology Bone DiseaseHealth SciencesPain MedicineRadionuclide TherapyMedicine	2004	73
Fully automated interpretation of ionizing radiation-induced γH2AX foci by the novel pattern recognition system AKLIDES<sup>®</sup> Roswitha Runge, Rico Hiemann, M Wendisch, International Journal of Radiation Biology	2012	60
Rhenium-188-HEDP in the Palliative Treatment of Bone Metastases Knut Liepe, R Hliscs, J. Kropp, Cancer Biotherapy and Radiopharmaceuticals	2000	49
Systemic radionuclide therapy in pain palliation Knut Liepe, Roswitha Runge, Jörg Kotzerke American Journal of Hospice and Palliative Medicine®	2005	40
Potential of a Cetuximab‐based radioimmunotherapy combined with external irradiation manifests in a 3‐D cell assay Mirjam Ingargiola, Roswitha Runge, Jan‐Martin Heldt, International Journal of Cancer Radiation EffectImmunologyImmunotherapyTumor BiologyCell Assay	2014	28
Comparison of the radiotoxicity of the <sup>99m</sup>Tc-labeled compounds <sup>99m</sup>Tc-pertechnetate, <sup>99m</sup>Tc-HMPAO and <sup>99m</sup>Tc-MIBI Ute Maucksch, Roswitha Runge, Gerd Wunderlich, International Journal of Radiation Biology	2016	25
New model for the induction of osteoblastic bone metastases in rat. Knut Liepe, H Geidel, Michael Haase, PubMed	2005	24
On the dose calculation at the cellular level and its implications for the RBE of<sup>99m</sup>Tc and<sup>123</sup>I Robert Freudenberg, Roswitha Runge, Ute Maucksch, Medical Physics	2014	20
Chromogranin A: an additional tumor marker for postoperative recurrence and metastases of medullary thyroid carcinomas? W.‐G. Franke, J. Pinkert, Roswitha Runge, PubMed Surgical OncologyPathologyChromogranin ARecurrent MtcPostoperative Recurrence	2001	19

Page 1